DNA Synthesis Market (By Service Type; By Application: Research And Development, Academic, Industrial, Diagnosis, Therapeutics; By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

The global DNA synthesis market was surpassed at USD 260.7 million in 2021 and is expected to hit around USD 513.80 million by 2030, growing at a CAGR of 7.83% from 2022 to 2030.

visionresearchreports.com/reportimg/DNA-Synthesis-Market-Size-2021-to-2030.jpg

DNA replication is the natural process of DNA synthesis. However, in the laboratory DNA is produced using genetic engineering and enzyme chemistry, artificially. This deoxyribonucleotide are used in genetic engineering, diagnostics, therapeutic applications, academic, and industrial use. Cost per base pair, error rates, lengths, and throughput, are some of the basic parameters that confirm the quality of synthesis from different companies.

Therapeutic application is continuously witnessing research and development for antibody discovery, immunology, cancer therapy, infectious disease, vaccines, and synthetic biology. The commercial growth of oligonucleotide therapeutics including miRNA inhibitors, siRNA, and oligos is supporting the growth of this segment. In comparison to traditional therapies, DNA synthesis therapeutic drugs have several potential and economic advantages. For instance, in September 2021, India gave emergency approval to Zydus Cadila’s ZyCoV-D, the first DNA vaccine, a highly stable, and cost-effective vaccine. Thus, the marketspace offers a lucrative opportunity for growth.

The application segment has been mainly categorized as:

  • Research and Development
  • Academic
  • Industrial
  • Diagnosis
  • Therapeutics

Scope of The Report

Report Coverage Details
Market Size in 2021 USD 260.7 million
Revenue Forecast by 2030 USD 513.80 million
Growth rate from 2022 to 2030 CAGR of 7.83%
Base Year 2021
Forecast Period 2022 to 2030
Segmentation Service Type, Application, End User, Region
Companies Covered

Thermo Fisher Scientific, Inc., Twist Bioscience, Bioneer Corporation, Eton Bioscience, LGC Biosearch Technologie, IBA GmbH, Eurofins Scientific, Integrated DNA Technologies, Inc., Quintara Biosciences, GenScript Biotech Corporation, and others

 

Furthermore, the human genome project is offering several advantages in technological processes for production and reduces the time of production. This enables the synthesis of the required sequence in the required time of high throughput custom nucleotides, accelerating the market growth. In addition, the commercial success of the multi-billion dollar PCR industry and Next-generation sequencing is boosting the market growth.

Startups’ entry into the DNA synthesis market is providing improved procedures for synthesis and innovations in the medical field. For instance, as of September 2022, U.S.-based startupSiolta Therapeutics’ STMC-103H, is in phase 2 clinical investigation. Biologic drug STMC-103H has been investigated for Atopic Dermatitis and Type 1 hypersensitivity, catering to new opportunities for market growth.

Key market players are continuously upgrading manufacturing technologies to obtain high throughput and cost-controlled synthesis. In 2017, Illumina announced an investment of USD 82 million in Twist biosciences to support the development of new technology for silicon-based deoxyribonucleotides synthesis. These players are undertaking various strategic initiatives on branding, market penetration, mergers & collaborations, expansion of manufacturing facilities, and geographical expansion.

Key Players

  • Thermo Fisher Scientific, Inc.
  • Twist Bioscience
  • Bioneer Corporation
  • Eton Bioscience
  • LGC Biosearch Technologie
  • IBA GmbH
  • Eurofins Scientific
  • Integrated DNA Technologies, Inc.
  • Quintara Biosciences
  • GenScript Biotech Corporation
  • others

Market Segmentation

By Service Type

  • Oligonucleotide Synthesis
    • Universal Oligonucleotide Synthesis
    • Custom Oligonucleotide Synthesis
  • Gene Synthesis
    • Custom Gene Synthesis
    • Gene Library Synthesis

By Application

  • Research and Development
  • Academic
  • Industrial
  • Diagnosis
  • Therapeutics

By End User

  • Biopharmaceutical Companies
  • Academic and Research Institutes
  • Contract Research Organizations

By Region

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa (MEA)

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on DNA Synthesis Market 

5.1. COVID-19 Landscape: DNA Synthesis Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global DNA Synthesis Market, By Service Type

8.1. DNA Synthesis Market, by Service Type, 2022-2030

8.1.1 Oligonucleotide Synthesis

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Universal Oligonucleotide Synthesis

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Custom Oligonucleotide Synthesis

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Gene Synthesis

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Custom Gene Synthesis

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Gene Library Synthesis

8.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global DNA Synthesis Market, By Application

9.1. DNA Synthesis Market, by Application, 2022-2030

9.1.1. Research and Development

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Academic

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Industrial

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Diagnosis

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Therapeutics

9.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global DNA Synthesis Market, By End User 

10.1. DNA Synthesis Market, by End User, 2022-2030

10.1.1. Biopharmaceutical Companies

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Academic and Research Institutes

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Contract Research Organizations

10.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global DNA Synthesis Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.1.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.3. Market Revenue and Forecast, by End User (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.4.3. Market Revenue and Forecast, by End User (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.5.3. Market Revenue and Forecast, by End User (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.2.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.3. Market Revenue and Forecast, by End User (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.4.3. Market Revenue and Forecast, by End User (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.5.3. Market Revenue and Forecast, by End User (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.6.3. Market Revenue and Forecast, by End User (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.7.3. Market Revenue and Forecast, by End User (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.3.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.3. Market Revenue and Forecast, by End User (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.4.3. Market Revenue and Forecast, by End User (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.5.3. Market Revenue and Forecast, by End User (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.6.3. Market Revenue and Forecast, by End User (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.7.3. Market Revenue and Forecast, by End User (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.3. Market Revenue and Forecast, by End User (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.4.3. Market Revenue and Forecast, by End User (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.5.3. Market Revenue and Forecast, by End User (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.6.3. Market Revenue and Forecast, by End User (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.7.3. Market Revenue and Forecast, by End User (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.3. Market Revenue and Forecast, by End User (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.4.3. Market Revenue and Forecast, by End User (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.5.3. Market Revenue and Forecast, by End User (2017-2030)

Chapter 12. Company Profiles

12.1. Thermo Fisher Scientific, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Twist Bioscience

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Bioneer Corporation

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Eton Bioscience

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. LGC Biosearch Technologie

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. IBA GmbH

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Eurofins Scientific

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Integrated DNA Technologies, Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Quintara Biosciences

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. GenScript Biotech Corporation

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers